COLLIDION INC.

Profile

Company Names

COLLIDION INC.

Addresses

1770 CORPORATE CIRCLE, PETALUMA, CA 94954

1770 CORPORATE CIRCLE, PENTALUMA, CA 94954

1356 GORDON LANE, SANTA ROSE, CA 95404

Phone Numbers

(707) 206-5326

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

NEVADA

Total Amount Raised:

$24,483,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-04-10 
$275,000.00 
$500,000.00 
$225,000.00 
Equity, Debt 
2
2016-02-29 
$9,953,000.00 
$11,000,000.00 
$1,047,000.00 
Equity 
1
2016-02-12 
$14,255,000.00 
$15,000,000.00 
$745,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HOJABR 
 
ALIMI 
EXECUTIVE OFFICER, DIRECTOR
PULMATRIX, INC.   |  RUTHIGEN, INC.   |  COLLIDION INC.   |  SPECTRUM ANTIMICROBIALS, INC.
GREGG 
 
ALTON 
DIRECTOR, EXECUTIVE OFFICER
CELLADON CORP   |  COLLIDION INC.   |  RENOVARO INC.
ETTORE 
M. 
CARINO 
DIRECTOR
COLLIDION INC.
JEFFREY 
 
CASTILLO 
DIRECTOR
COLLIDION INC.
MARK 
 
FENLON 
DIRECTOR
COLLIDION INC.
GREGORY 
 
FRENCH 
DIRECTOR
PULMATRIX, INC.   |  RUTHIGEN, INC.   |  COLLIDION INC.
SAMEER 
 
HARISH 
EXECUTIVE OFFICER
PULMATRIX, INC.   |  RUTHIGEN, INC.   |  COLLIDION INC.   |  SPECTRUM ANTIMICROBIALS, INC.
ELLIOT 
 
MAZA 
EXECUTIVE OFFICER
COLLIDION INC.   |  TRULI MEDIA GROUP, INC.
WILLIAM 
H. 
WATSON 
EXECUTIVE OFFICER
COLLIDION INC.   |  SPECTRUM ANTIMICROBIALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-31
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-12 
2019-08-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-04-10 
2019-07-03
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-12 
2019-03-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-12 
2018-01-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-29 
2017-01-04
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-29 
2016-03-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
F.F. LAFFERTY + CO., INC.
2498
GUY B CRAWFORD
864093